Menu

Filters

  • Result Found In

MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Pk

MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Pk

Pharmacy / Vaccine / 5580110 | Merck Vaccines - 00006468100
  2. /
  3. Supplies & Small Equipment
  4. /
  5. Browse Supplies
  6. /
  7. Category: Pharmacy
  8. /
  9. MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Pk
MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Pk
Compare
  • Category:
    Pharmacy / Vaccine / MMR
  • UNSPSC:
    51201628
  • Billing NDC#
    00006468100
  • NDC#
    0006468100
  • AHFS:

    AHFS® Pharmacologic/Therapeutic Classification© used with permission. © 2021, the American Society of Health-System Pharmacists, Inc. (ASHP). The Data is a part of the AHFS Drug Information®; ASHP is not responsible for the accuracy of transpositions from the original context.

    80120000 Vaccines

  • MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Pk 5580110 | Merck Vaccines - 00006468100

  • Description:
    MMR II Mumps Rubella Injectable 0.5mL Powder for Solution SDV 10/Package
  • Category:
    Pharmacy / Vaccine
  • UNSPSC:
    51201628
  • Billing NDC#
    00006468100
  • NDC#
    0006468100
  • AHFS:

    AHFS® Pharmacologic/Therapeutic Classification© used with permission. © 2021, the American Society of Health-System Pharmacists, Inc. (ASHP). The Data is a part of the AHFS Drug Information®; ASHP is not responsible for the accuracy of transpositions from the original context.

    80120000 Vaccines
  • Packaging Options (1)

Product Overview Product feature summary

M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) is a live virus vaccine for vaccination against measles (rubeola) mumps, and rubella (German measles).

Features & Benefits:

  • • 0.5-mL SDV with Diluent
  • • The dose for any age is 0.5 mL administered subcutaneously, preferably into the outer aspect of the upper arm
  • • The recommended age for primary vaccination is 12 to 15 months
  • • It is important to use a separate sterile syringe and needle for each individual patient to prevent transmission of hepatitis B and other infection agents from one person to another
  • • Single Dose Vial

Specifications Product specifications and dimensions

  • Additional Attributes
    Powder for Solution
  • Brand/Item
    MMR II
  • Composition/Ingredients
    Mumps Rubella
  • Container Type
    SDV
  • Dosage Form
    Injectable
  • Quantity
    10/Package
  • Strength
    0.5mL

Continue Shopping Add to Cart
Henry Schein Henry Schein